MINERVA NEUROSCIENCES INC (NERV) Stock Analyst Ratings
NASDAQ:NERV - Nasdaq - US6033802058 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to NERV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 167.02% above the current price.
NERV was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about NERV.
In the previous month the buy percentage consensus was at a similar level.
NERV was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-06 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-08-07 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-05-02 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-02-27 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-08-02 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2023-05-16 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-05-02 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-03-09 | HC Wainwright & Co. | Reiterate | Neutral |
| 2022-11-10 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-10-17 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2022-03-04 | HC Wainwright & Co. | Maintains | Buy |